
News|Articles|August 1, 2013
Analytical Method Development Life Cycle
Michael Rooney, director, bioanalytical development at Jazz Pharmaceuticals, provides an overview of a life cycle strategy for analytical methods development, the need for standards and guidance documents, and therole Quality by Design can play in method development.
Advertisement
Michael Rooney, director, bioanalytical development at Jazz Pharmaceuticals, provides an overview of a life cycle strategy for analytical methods development, the need for standards and guidance documents, and the role Quality by Design can play in method development.
The
2013 PDA Analytical Methods Development & Validation Workshop, Oct. 7-8 at the Renaissance Baltimore Harborplace
addresses these topics.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Leveraging an Innovative Mid-Scale Manufacturing Solution to Meet Diverse Needs
2
Renewing Prosaic Generics for Cancer Treatment
3
Viral Safety 2.0: Plant-Ready Actions for ICH Q5A(R2) Compliance
4
Faster Doesn’t Mean Easier: Development Impacts of a New Biosimilar Regulatory Landscape
5




